Literature DB >> 18690372

[Myocardial perfusion scintigraphy 2006 in Germany. Results of the query and current status].

O Lindner1, W Burchert, F M Bengel, R Zimmermann, J Vom Dahl, W Schäfer, O Schober, R Kluge, M Schäfers.   

Abstract

AIM: This second survey was to deliver further information on myocardial perfusion scintigraphy (MPS) in Germany in 2006.
METHOD: 351 questionnaires were evaluated: 207 private practices (PP), 117 hospitals (HO), 27 from university hospitals (UH).
RESULTS: MPS of 106 331 patients were reported, 85% were investigated with (99m)Tc-perfusion tracers. 74% [2005 = 72%] were performed in PP, 17% [2005 = 15%] in HO and 9% [2005 = 13%] in UH. PP, which participated in 2005 and 2006, demonstrated an increase by 3,9% (HO 0%, UH - 13,0%). The type of stress was pharmacological in 27% [2005 = 22%]; 54% adenosine (of these 29% with exercise), 37% dipyridamole (of these 56% with exercise), and 9% dobutamine. Gated SPECT was performed in 42% [2005 = 36%] of all rest- and in 39% [2005 = 32%] of all stress MPS. An attenuation correction was used by 69 [2005 = 78] institutions. 40% of all MPS were performed in patients suspected to have CAD. 24% of all institutions reported changes in the use of MPS by competing methods.
CONCLUSION: There is a small increase of MPS between 2005 and 2006 despite competing methods. Gated SPECT has experienced more acceptance. Suspicion of CAD is an important indication of MPS. In order to tap the full potential of MPS a gated SPECT should be performed routinely.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18690372

Source DB:  PubMed          Journal:  Nuklearmedizin        ISSN: 0029-5566            Impact factor:   1.379


  4 in total

1.  Appropriateness of referrals for single-photon emission computed tomography myocardial perfusion imaging (SPECT-MPI) in a developing community: a comparison between 2005 and 2009 versions of ACCF/ASNC appropriateness criteria.

Authors:  Ali Gholamrezanezhad; Ahmadali Shirafkan; Sahar Mirpour; Mehdi Rayatnavaz; Azita Alborzi; Mehdi Mogharrabi; Sepideh Hassanpour; Mohammadali Ramezani
Journal:  J Nucl Cardiol       Date:  2011-08-05       Impact factor: 5.952

2.  Myocardial perfusion scintigraphy in Germany in 2009: utilization and state of the practice.

Authors:  Oliver Lindner; Wolfgang Burchert; Frank M Bengel; Rainer Zimmermann; Jürgen Vom Dahl; Michael Schäfers
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-04-19       Impact factor: 9.236

3.  Myocardial perfusion SPECT 2015 in Germany. Results of the 7th survey.

Authors:  Oliver Lindner; Wolfgang Burchert; Wolfgang Schäfer; Marcus Hacker
Journal:  Nuklearmedizin       Date:  2016-12-02       Impact factor: 1.379

4.  Use of myocardial perfusion imaging and estimation of associated radiation doses in Germany from 2005 to 2012.

Authors:  O Lindner; F M Bengel; M Hacker; W Schäfer; W Burchert
Journal:  Eur J Nucl Med Mol Imaging       Date:  2014-02-12       Impact factor: 9.236

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.